EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bariatric Surgery Outcomes in Patients with Chronic Kidney Disease

Adriana Pané iD, Maria Claro, Alicia Molina-Andujar iD, Romina Olbeyra, Bárbara Romano-Andrioni iD, Laura Boswell iD, Enrique Montagud-Marrahi iD, Amanda Jiménez, Ainitze Ibarzabal, Judith Viaplana iD, Pedro Ventura-Aguiar iD, Antonio J Amor iD und 3 weitere

Journal of Clinical Medicine · 21.09.2023 · 12 (18) · 6095

DOI: 10.3390/jcm12186095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.09.2023. Verfasst von Adriana Pané und 14 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Nutrition Department, Hospital Clínic de Barcelona, Villarroel 170, 08036 Barcelona, Spain. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pla Estratègic de Recerca i Innovació en Salut. (PERIS). Generalitat de Catalunya., Hospital Clínic de Barcelona. Ajut a la Recerca Josep Font, the “Pla Estratègic de Recerca i Innovació en Salut” (PERIS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity increases the risk of developing chronic kidney disease (CKD), which has a major negative impact on global health. Bariatric surgery (BS) has demonstrated a substantial improvement of obesity-related comorbidities and thus, it has emerged as a potential therapeutic tool in order to prevent end-stage renal disease. A limited number of publications to date have examined the beneficial effects and risks of BS in patients with non-advanced stages of CKD. We aimed to investigate the safety of BS in patients with CKD stages 3–4 (directly related or not to obesity) and both the metabolic/renal outcomes post-BS. A total of 57 individuals were included (n = 19 for CKD-group; n = 38 for patients with obesity, but normal eGFR [control-group]). Weight loss and obesity comorbidities resolution after BS were similar in both groups. Renal function (eGFR [CKD-EPI]) improved significantly at the 1-year follow-up: Δ10.2 (5.2–14.9) (p < 0.001) for CKD-group and Δ4.0 (−3.9–9.0) mL/min/1.73 m2 (p = 0.043) for controls. Although this improvement tended to decrease in the 5-year follow-up, eGFR remained above its basal value for the CKD-group. Noteworthy, eGFR also improved in those patients who presented CKD not directly attributed to obesity. For patients with CKD, BS appears to be safe and effective regarding weight loss and obesity comorbidities resolution, irrespective of the main cause of CKD (related or not to obesity).

Schlagwörter

Stichwörter der Autor:innen

Roux-en-Y Gastric Bypassbariatric surgerychronic kidney diseasesleeve gastrectomyweight lossweight regain

Autor:innen und Institutionen

  • Endocrinology and Nutrition Department, Hospital Clínic de Barcelona, Villarroel 170, 08036 Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
  • Nephrology and Kidney Transplantation Department, Hospital Clinic de Barcelona, 08036 Barcelona, Spain.
  • Endocrinology and Nutrition Department, Althaia Universitary Health Network, 08243 Manresa, Spain.
  • Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS)-Fundació Clínic per a la Recerca Biomèdica (FCRB), 08036 Barcelona, Spain.
  • Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Centre de recerca biomèdica Cellex (CRB CELLEX), Fundació Clinic, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), 08036 Barcelona, Spain.

ORCID-Profile: Adriana Pané, Alicia Molina-Andujar, Bárbara Romano-Andrioni, Laura Boswell, Enrique Montagud-Marrahi, Judith Viaplana, Pedro Ventura-Aguiar, Antonio J Amor, Lilliam Flores, Ana de Hollanda

Förderung

  • Pla Estratègic de Recerca i Innovació en Salut. (PERIS). Generalitat de Catalunya.
  • Hospital Clínic de Barcelona. Ajut a la Recerca Josep Font
  • the “Pla Estratègic de Recerca i Innovació en Salut” (PERIS)
  • the “Ajut a la Recerca Josep Font, 2018” (Hospital Clinic, Barcelona)

Zitieren

APA

Pané, A., Claro, M., Molina-Andujar, A., Olbeyra, R., Romano-Andrioni, B., Boswell, L., Montagud-Marrahi, E., Jiménez, A., Ibarzabal, A., Viaplana, J., Ventura-Aguiar, P., Amor, A. J., Vidal, J., Flores, L., & de Hollanda, A. (2023). Bariatric Surgery Outcomes in Patients with Chronic Kidney Disease. Journal of Clinical Medicine, 12(18), 6095. https://doi.org/10.3390/jcm12186095

Vancouver

Pané A, Claro M, Molina-Andujar A, Olbeyra R, Romano-Andrioni B, Boswell L, et al. Bariatric Surgery Outcomes in Patients with Chronic Kidney Disease. Journal of Clinical Medicine. 2023;12(18):6095. doi:10.3390/jcm12186095

BibTeX
@article{Pan2023,
  author = {Pané, Adriana and Claro, Maria and Molina-Andujar, Alicia and Olbeyra, Romina and Romano-Andrioni, Bárbara and Boswell, Laura and Montagud-Marrahi, Enrique and Jiménez, Amanda and Ibarzabal, Ainitze and Viaplana, Judith and Ventura-Aguiar, Pedro and Amor, Antonio J and Vidal, Josep and Flores, Lilliam and de Hollanda, Ana},
  title = {Bariatric Surgery Outcomes in Patients with Chronic Kidney Disease},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {18},
  pages = {6095},
  doi = {10.3390/jcm12186095}
}
Kostenlos starten →